Dataset Information


Ligand-dependent disorder of the Omega loop observed in extended-spectrum SHV-type beta-lactamase.

ABSTRACT: Among Gram-negative bacteria, resistance to β-lactams is mediated primarily by β-lactamases (EC, periplasmic enzymes that inactivate β-lactam antibiotics. Substitutions at critical amino acid positions in the class A β-lactamase families result in enzymes that can hydrolyze extended-spectrum cephalosporins, thus demonstrating an "extended-spectrum" β-lactamase (ESBL) phenotype. Using SHV ESBLs with substitutions in the Ω loop (R164H and R164S) as target enzymes to understand this enhanced biochemical capability and to serve as a basis for novel β-lactamase inhibitor development, we determined the spectra of activity and crystal structures of these variants. We also studied the inactivation of the R164H and R164S mutants with tazobactam and SA2-13, a unique β-lactamase inhibitor that undergoes a distinctive reaction chemistry in the active site. We noted that the reduced Ki values for the R164H and R164S mutants with SA2-13 are comparable to those with tazobactam (submicromolar). The apo enzyme crystal structures of the R164H and R164S SHV variants revealed an ordered Ω loop architecture that became disordered when SA2-13 was bound. Important structural alterations that result from the binding of SA2-13 explain the enhanced susceptibility of these ESBL enzymes to this inhibitor and highlight ligand-dependent Ω loop flexibility as a mechanism for accommodating and hydrolyzing β-lactam substrates.


PROVIDER: S-EPMC3088229 | BioStudies | 2011-01-01


REPOSITORIES: biostudies

Similar Datasets

2006-01-01 | S-EPMC2593906 | BioStudies
2009-01-01 | S-EPMC2650538 | BioStudies
2014-01-01 | S-EPMC3894197 | BioStudies
2018-01-01 | S-EPMC6125571 | BioStudies
2012-01-01 | S-EPMC3523351 | BioStudies
2011-01-01 | S-EPMC3122419 | BioStudies
2001-01-01 | S-EPMC90245 | BioStudies
2001-01-01 | S-EPMC90669 | BioStudies
2019-01-01 | S-EPMC6591606 | BioStudies
2005-01-01 | S-EPMC1087612 | BioStudies